Trial intelligence / Profile preview

Triumeq in HIV-infected Patients 60 Years and Older

NCT02509195Phase 4Completed

Sponsor
St Stephen's AIDS Trust
Start
Aug 2015
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of abacavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by St Stephen's AIDS Trust. Started Aug 2015; status: completed.

02

Drugs

abacavir
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT02509195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02509195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call